Avène Hyaluron Activ Procedure Hexapeptide Serum (20 ml)
- Livraison gratuite dès 49 CHF
- Pharmaciens à votre écoute
- Paiement 100% sécurisé
Couldn't load pickup availability
Eau Thermale Avène HYALURON ACTIV PROCEDURE Lifting Booster Serum - 10% Hexapeptide solution
With HYALURON ACTIV PROCEDURE, Avène Dermatological Laboratories are launching an innovation: a range developed in collaboration with aesthetic dermatologists, which brings the latest advances in aesthetic dermatology to dermo-cosmetics.
This lifting serum is an innovation featuring a highly concentrated cocktail of anti-aging active ingredients with clinically proven efficacy*. It corrects 5 signs of skin aging in 14 days: wrinkles (expression lines, forehead wrinkles, crow's feet, nasolabial folds), volume, firmness, radiance, and complexion**.
After 14 days, SKIN LOOKS 2 YEARS YOUNGER***. Clinically proven efficacy.
The smoothing anti-wrinkle effect with a lifting effect is based on a trio of active ingredients recognized in aesthetic medicine, offered in pure and concentrated form:
- [10% HEXAPEPTIDE SOLUTION]: inspired by the mechanism of Botox injections, it contains a powerful anti-aging peptide that effectively reduces the appearance of wrinkles.
- [6% NIACINAMIDE]: stimulates cells and extends their lifespan**** to fight the signs of aging.
- [1% HYALURONIC ACID]: hydrates, smooths, and plumps the skin.
This reconstitutable serum is inspired by the practice of aesthetic dermatologists: an active ingredient is released at the last minute to ensure its most potent form and effective results in record time*****.
Can be used alone or in combination with aesthetic treatments. Clinically proven efficacy in combination with aesthetic treatments such as laser, injections, or peels.
The light gel texture is non-sticky and easily absorbed by the skin.
94% of ingredients are of natural origin. Fragrance-free, alcohol-free, paraben-free. Vegan.
*In Avène Dermatological Laboratories.
**Real-life conditions test, 72 consumers over 14 days.
***Evaluation after 2 weeks of twice-daily application based on a clinical assessment from a database, in 40 subjects.
****In vitro test.
*****Clinical study, 40 subjects, 2 applications per day for 14 days.
